1.The seal-up of pleuropulmonary fistula after pulmonary resection c tisseel.
Doo Yun LEE ; Hae Gyun KIM ; Dong Suck MOON
The Korean Journal of Thoracic and Cardiovascular Surgery 1991;24(10):1039-1043
No abstract available.
Fibrin Tissue Adhesive*
;
Fistula*
2.Clinical features of bee venom anaphylaxis.
Sung Gyun AHN ; Sun Sin KIM ; Hee Yeon KIM ; Dong Ho NAHM ; Hae Sim PARK
Journal of Asthma, Allergy and Clinical Immunology 1999;19(3):492-497
Background and OBJECTIVE: There has been a few case reports of anaphylaxis due to honeybee in Korea. In order to observe the clinical feature of bee sting anaphylaxis. Moderials and methods: Six patients living in Kyunggi province area were referred under history of anaphylaxis after the bee sting. Atopy was defined by skin prick test result to common inhalant allergen. Serum specific IgE antibody to each bee antigen was detected by radioimmunoassay to identify the causative bee. RESULTS: All six cases were female. Three had atopy and four had combined allergic diseases such as allergic rhinitis, asthma, and urticaria. The etiologic bees consisted of yellow jacket (6 cases), paper wasp (4 cases), yellow hornet (3 cases), white faced hornet (1 case) and honey bee (1 case). Four cases had experienced anaphylaxis after ant bite and they showed positive result on specific IgE to imported fire ant. Specific immunotherapy against causative bee venom was begun using bee venom extracts from Bayer (USA) based upon results of specific IgE anti-body to bee venom. CONCLUSION: The yellow jacket is the most common cause of bee venom anaphylaxis in this area. Further studies will be needed to evaluate possible cross-reactivity between bee and ant venom.
Anaphylaxis*
;
Ant Venoms
;
Ants
;
Asthma
;
Bee Venoms*
;
Bees*
;
Bites and Stings
;
Female
;
Fires
;
Gyeonggi-do
;
Honey
;
Humans
;
Immunoglobulin E
;
Immunotherapy
;
Korea
;
Radioimmunoassay
;
Rhinitis
;
Skin
;
Urticaria
;
Wasps
3.Differential Expression of Glucose Transporter Gene in Mouse Early Embryos.
Hye won YOUM ; Hye kyung BYUN ; Gyun ji SONG ; Hae kwon KIM ; Ho Joon LEE
Korean Journal of Fertility and Sterility 1998;25(1):77-86
The uptake of glucose for metabolism and growth is essential to most animal cells and is mediated by glucose-transporter (GLUT) proteins. The aim of this study was to determine which class of glucose transporter molecules was responsible for uptake of glucose in the mouse early embryo and at which stage the corresponding genes were expressed. In addition, co-culture system with vero cell was used to investigate the effect of the system on GLUT expression. Two-cell stage embryos were collected from the superovulated ICR female and divided into 3 groups. As a control, embryos were cultured in 0.4% BSA-T6 medium which includes glucose. For the experimental groups, embryos were cultured in either co-culture system with vero cells or glucose-free 76 medium supplemented with 0.4% BSA and pyruvate as an energy substrate. 2-cell to blastocyst stage embryos in those groups were respectively collected into microtubes (50 embryos/tube). Total RNA was extracted and RT-PCR was performed. The products were analysed after staining ethidium bromide by 2% agarose gel electrophoresis. Blastocysts were collected from each group at 120hr after hCG injection. They were fixed in 2.5% glutaraldehyde, stained with hoechst, and mounted for observation. In control, GLUT1 was expressed from 4-cell to blastocyst. GLUT2 and GLUT3 were expressed in morula and blastocyst. GLUT4 was expressed in all stages. When embryos were cultured in glucose-free medium, no significant difference was shown in the expression of GLUTI1, 2 and 3, compared to control. However GLUT4 was not expressed until morular stage. When embryos were co-cultured with vero cell, there was no significant difference in the expression of GLUT1, 2, 3 and 4 compared to control. To determine cell growth of embryos, the average cell number of blastocyst was counted. The cell number of co-culture (93.8+/-3.1, n=35) is significantly higher than that of control and glucose-free group (76.6 +/- 3.8, n=35 and 68.2+/-4.3, n=30). This study shows that the GLUT genes are expressed differently according to embryo stage. GLUTs were detectable throughout mouse preimplantation development in control and co-culture groups. However, GLUT4 was not detected from 2- to 8-cell stage but detected from morula stage in glucose-free medium, suggested that GLUT genes are expressed autocrinally in the embryo regardless of the presence of glucose as an energy substrate. In addition, co-culture system can increase the cell count of blastocyst but not improve the expression of GLUT. In conclusion, expression of GLUT is dependent on embryo stage in preimplantation embryo development.
Animals
;
Blastocyst
;
Cell Count
;
Coculture Techniques
;
Electrophoresis, Agar Gel
;
Embryonic Development
;
Embryonic Structures*
;
Ethidium
;
Female
;
Glucose Transport Proteins, Facilitative*
;
Glucose*
;
Glutaral
;
Humans
;
Metabolism
;
Mice*
;
Morula
;
Pregnancy
;
Pyruvic Acid
;
RNA
;
Vero Cells
4.Treatment of a Giant Serpentine Aneurysm in the Anterior Cerebral Artery.
Sung Tae KIM ; Young Gyun JEONG ; Hae Woong JEONG
Journal of Cerebrovascular and Endovascular Neurosurgery 2016;18(2):141-146
A giant serpentine aneurysm (GSA) in the anterior cerebral artery (ACA) poses a technical challenge in treatment given its large size, unique neck, and dependent distal vessels. Here we report the case of a GSA in the ACA successfully treated with a combined surgical and endovascular approach. A 54-year-old woman presented with dull headache. On brain computed tomography (CT), a large mass (7 cm × 5 cm × 5 cm) was identified in the left frontal lobe. Cerebral angiography revealed a GSA in the left ACA. Bypass surgery of the distal ACA was performed, followed byocclusion of the entry channel via an endovascular approach. Follow-up CT performed 5 days after treatment revealed disappearance of the vascular channel and peripheral rim enhancement. Follow-up imaging studies performed 7 months after treatment revealed gradual reduction of the mass effect and patency of bypass flow. No complications were noted over a period of 1 year after surgery.
Aneurysm*
;
Anterior Cerebral Artery*
;
Brain
;
Cerebral Angiography
;
Cerebral Revascularization
;
Female
;
Follow-Up Studies
;
Frontal Lobe
;
Headache
;
Humans
;
Intracranial Aneurysm
;
Middle Aged
;
Neck
5.Two Cases of Scar endometriosis.
Young Bok PARK ; Je Hun JO ; Won Yeon JANG ; Tae Hyoung PARK ; Do Gyun KIM ; Hae Won YOON
Korean Journal of Gynecologic Oncology and Colposcopy 2001;12(1):47-51
Endometriosis is defined as the presence of endometrial tissue(gland and stroma) outside the uterus. The incidence of scar endometriosis is quite rare, and must differentiate with cellulitis and abscess. We have experienced one case of perineal endometriosis and one case of abdominal wall endometriosis at the site of postoperative wound scar. The possible pathogenesis of endometriosis and treatment were discussed.
Abdominal Wall
;
Abscess
;
Cellulitis
;
Cicatrix*
;
Endometriosis*
;
Female
;
Incidence
;
Uterus
;
Wounds and Injuries
6.A case of intravenous immunoglobulin therapy in severe aspirin - sensitive asthma patient combined with IgG1 and IgG3 subclass deficiency.
Hae Sim PARK ; Hee Yeon KIM ; Dong Ho NAHM ; Sang Yong YOO ; Sung Gyun AHN ; Dong Suk HAN
Journal of Asthma, Allergy and Clinical Immunology 1999;19(4):610-614
Common complications in a patient with IgG subclass deficiency include recurrent respiratory infections and concomitant inflammatory lung disease. The most effective therapy in these patients is the administration of intravenous immunoglobulin. The authors report a case of severe aspirin-sensitive asthma and recurrent pneumonia with combined IgG1, and IgG3 subclass deficiency in a 19-year-old man. The patient was treated with 0.4g/kg at monthly intervals for 6 months, and is still receiving 0.2g/kg every 2 weeks at our clinic. After the replacement of intravenous immunoglobulin, the patient has clinically improved.
Aspirin*
;
Asthma*
;
Humans
;
Immunization, Passive*
;
Immunoglobulin G*
;
Immunoglobulins*
;
Lung Diseases
;
Pneumonia
;
Respiratory Tract Infections
;
Young Adult
7.Coiling as Retreatment in Intracranial Aneurysm of de novo Formation or Regrowth: Case Report.
Sung Tae KIM ; Hae Woong JEONG ; Young Gyun JEONG ; Hyun Sin IN
Neurointervention 2013;8(1):46-51
Development of de novo aneurysm or aneurysm regrowth after complete clipping of an intracranial aneurysm is rare. We report coiled cases of de novo aneurysm and aneurysm regrowth. We retrospectively reviewed 107 cases of intracranial aneurysm coiling performed in our hospital, identifying five cases of coiled aneurysm that were de novo aneurysm or aneurysm regrowth. In all the cases, total or near total occlusion was seen. There were no complications related to the procedure. In two of the three patients with ruptured aneurysms, consciousness level on admission was stupor. When the patient was discharged after the treatment, one of them had 4 of the modified Rankin Scale. The other one had 5 on discharge. The rest three patients had 0. As for a de novo aneurysm or a regrowth of aneurysm, coiling may be considered when clipping is difficult.
Aneurysm
;
Aneurysm, Ruptured
;
Consciousness
;
Humans
;
Intracranial Aneurysm
;
Retreatment
;
Retrospective Studies
;
Stupor
;
Subarachnoid Hemorrhage
8.Choriocarcinoma in the Pulmonary Artery Diagnosed and Treated by Emergency Pulmonary Embolectomy.
Bhong Gyun JO ; Jong In KIM ; Hae Young LEE ; Sung Dal PARK ; Song Myung KIM ; Young Ok KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 2003;36(7):531-534
A 43-year-old woman who had had an invasive mole 5 years previously required emergent pulmonary embolectomy under cardiopulmonary bypass. Curative resection was impossible because the tumor invaded the right main pulmonary artery and left lower pulmonary artery. The pathologic diagnosis made by the tumor emboli specimens was choriocarcinoma. The patient received post-operative chemotherapy over a 6-month period and had complete remission. Although rare, choriocarcinoma should be considered in the differential diagnosis of fertile women presented with pulmonary embolism.
Adult
;
Cardiopulmonary Bypass
;
Choriocarcinoma*
;
Diagnosis
;
Diagnosis, Differential
;
Drug Therapy
;
Embolectomy*
;
Emergencies*
;
Female
;
Humans
;
Hydatidiform Mole, Invasive
;
Pregnancy
;
Pulmonary Artery*
;
Pulmonary Embolism
9.Human Lung Cancer Cell Xenografts Implanted under the Capsule of Kidney, Spleen and Liver.
Soo Hyun KIM ; Jong In KIM ; Hae Young LEE ; Bhong Gyun JO ; Sung Dal PARK ; Song Myung KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 2003;36(10):711-720
BACKGROUND: Complete resection by the surgery has been selected as the treatment of choice in lung cancer patients, but in cases of recurrence after excision or inoperable cases, the importance of anticancer chemotherapy has been emphasized. If one can select a set of the sensitive chemotherapeutic agents before anticancer chemotherapy, it will give more favourable results. Subrenal capsular assay has been recognized as a useful in-vivo chemosensitivity test of thoracic and abdominal tumors and it can be done in a short time for a rapid interpretation of tumor responsiveness to anticancer chemotherapeutic drugs. It has been reported that various kinds of cancer cells can be implantable to the kidney, but so far there is no comparative study of xenogeneic cell implantation on liver, spleen and kidney. The author implanted the human lung cancer cells under the capsule of S.D rat's liver, spleen and kidney respectively and compared the pattern of growth and histology. MATERIAL AND METHOD: After incubation of human lung cancer cell line (SW-900 G IV) in RPMI 1640 (Leibovitz L-15 medium) culture media, 3x3x3 mm size fibrin clots which contain 108 cancer cells were made. Thereafter the fibrin clots were implanted at subcapsule area of liver, spleen and kidney of S.D. female rat. For immune suppression, cyclosporin-A (80 mg/Kg) was injected subcutaneously daily from post-implantation first day to sixth day. The body weight was measured at pre and post implantation periods. The growth pattern and the size of tumor mass were observed and the pathologic examination and serum tumor marker tests were performed. RESULT: Body weight increased in both of control and experimental groups. Serum Cyfra 21-1 was not detected. Serum levels of CEA and NSE revealed no significant change. The SCC-Ag increased significantly in implanted group. The growth rate of human lung cancer cells which was implanted on spleen was higher than on liver or kidney. The surface area, thickness, and volume of tumor mass were predominant at spleen. The success rates of implantation were 80% on kidney, 76.7% on spleen and 43.3% on liver. Pathologic examination of implanted tumors showed characteristic findings according to different organs. Tumors that were implanted on kidney grew in a round shape, small and regular pattern. In the spleen, tumors grew well and microscopic neovascularization and tumor thrombi were also found, but the growth pattern was irregular representing frequent daughter mass. Human lung cancer cells that were implanted in the liver, invaded to the liver parenchyme, and had low success rate of implantation. Microscopically, coagulation necrosis and myxoid fibrous lesion were observed. CONCLUSION: The success rate of implantation was highest in the kidney. And the mass revealed regular growth that could be measured easily. The SCC-Ag was presented earlier than CEA or Cyfra21-1. The Cyfra21-1 was not detected at early time after implantation. The best model for tumor implantation experiment for chemosensitivity test was subrenal capsular analysis than liver and spleen and the useful serum tumor marker in early period of implantation was the SCC-Ag.
Animals
;
Body Weight
;
Cell Line
;
Cell Transplantation
;
Culture Media
;
Drug Therapy
;
Female
;
Fibrin
;
Heterografts*
;
Humans*
;
Kidney*
;
Liver*
;
Lung Neoplasms*
;
Lung*
;
Models, Animal
;
Necrosis
;
Nuclear Family
;
Rats
;
Recurrence
;
Spleen*
10.The influence of adjuvant radiotherapy on patterns of failure and survivals in uterine carcinosarcoma.
Hae Jin PARK ; Hak Jae KIM ; Hong Gyun WU ; Hans KIM ; Sung Whan HA ; Soon Beom KANG ; Yong Sang SONG ; Noh Hyun PARK ; Jae Won KIM
Radiation Oncology Journal 2011;29(4):228-235
PURPOSE: To evaluate the impact of postoperative radiotherapy (PORT) on patterns of failure and survivals in uterine carcinosarcoma patients treated with radical surgery. MATERIALS AND METHODS: Between October 1998 and August 2010, 19 patients with stage I-III uterine carcinosarcoma received curative hysterectomy and bilateral salpingo-oophorectomy with or without PORT at Seoul National University Hospital. Their hospital medical records were retrospectively reviewed. PORT and non-PORT groups included 11 and 8 patients, respectively. They were followed for a mean of 22.7 months (range, 7.8 to 126.6 months). RESULTS: At 5 years, the overall survival rates were 51.9% for entire, 61.4% for PORT, and 41.7% for non-PORT groups, respectively. There was no statistical difference between PORT and non-PORT groups with regard to overall survival (p = 0.682). Seven out of 19 (36.8%) patients showed treatment failures, which all happened within 12 months. Although the predominant failures were distant metastasis in PORT group and loco-regional recurrence in non-PORT group, there was no statistically significant difference in loco-regional recurrence-free survival (LRRFS) (p = 0.362) or distant metastasis-free survival (DMFS) (p = 0.548). Lymph node metastasis was found to be a significant prognostic factor in predicting poor LRRFS (p = 0.013) and DMFS (p = 0.021), while the International Federation Gynecology and Obstetrics (FIGO) stage (p = 0.043) was associated with LRRFS. CONCLUSION: Considering that adjuvant radiotherapy after surgical resection was effective to decrease loco-regional recurrence and most treatment failures were distant metastasis, multimodal therapy including surgery, radiotherapy, and chemotherapy might be an optimal treatment for uterine carcinosarcoma patients.
Carcinosarcoma
;
Gynecology
;
Humans
;
Hysterectomy
;
Lymph Nodes
;
Medical Records
;
Neoplasm Metastasis
;
Obstetrics
;
Radiotherapy, Adjuvant
;
Recurrence
;
Retrospective Studies
;
Survival Rate
;
Treatment Failure
;
Uterus